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 We characterized the first blaVIM-possessing K. michiganensis isolate (BD-50-Km) 
 The strain was isolated from the rectal swab of a Turkish patient in Switzerland 
 blaVIM-1 was inserted in a rare class 1 integron harbored by a novel IncC plasmid 
 Core-genome analysis showed that BD-50-Km was not closely-related to other K. 
michiganensis deposited in NCBI 
 The backbone of the blaVIM-1-carrying plasmid was common to other IncC plasmids, 
but its resistance region was unique 
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Background. Klebsiella michiganensis is an emerging pathogen. As for Klebsiella 
pneumoniae, this species is able to acquire antibiotic resistance genes (ARGs) via mobile 
genetic elements. In this context, K. michiganensis isolates producing carbapenemases of 
KPC, NDM, IMP and OXA-48-like types have been already reported. Here, we characterized 
a strain (BD-50-Km) isolated from the rectal swab of a Turkish patient hospitalized in 
Switzerland.  
Methods. Species identification was initially obtained by using the MALDI-TOF MS. 
Susceptibility tests were done by the microdilution method. Whole-genome sequencing 
(WGS) was performed with both Illumina and Nanopore platforms and used to confirm ID, 
characterize plasmids and perform core-genome analyses.  
Results. BD-50-Km was initially identified as Klebsiella oxytoca and showed a reduced 
susceptibility to imipenem. However, WGS indicated that the isolate was actually K. 
michiganensis. BD-50-Km carried the blaVIM-1 associated to a rare class 1 integron (In87) 
located in a pST1 196kb IncC plasmid. This plasmid shared its backbone with many other 
IncC plasmids found in different species (including 5 K. michiganensis), but not the same 
In87 and the remaining region harboring various ARGs. BD-50-Km belonged to the novel 
ST342. Moreover, core-genome analysis (single nucleotide variants analysis) showed that 
BD-50-Km was not closely-related to any of the K. michiganensis strains deposited in NCBI 
(n=212), including the 38 so far reported as possessing carbapenemase genes. 
Conclusions. This is the first report of a blaVIM-possessing K. michiganensis clinical isolate. 
The spread of plasmid-mediated VIM carbapenemases in this emerging pathogen represent an 
additional threat to our therapeutic armamentarium.  
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Klebsiella michiganensis is emerging as an important human pathogen. Since its first report 
from a toothbrush holder in 2013, K. michiganensis isolates have been associated to 
nosocomial infections [1, 2]. For instance, an ESBL producer was responsible for an outbreak 
in a neonatal unit in Queensland (Australia) in 2018 [3], NDM-1 carbapenemase producers - 
that may also co-produce OXA-181 - were isolated from patients in South Africa during 
2012-2013 [4, 5], and a strain simultaneously producing KPC-2, NDM-1, NDM-5 
carbapenemases was detected in a patient with acute diarrhoea in 2016 in China [2]. With 
regard to Europe, the first KPC-3-producing K. michiganensis strain from a clinical patient 
was isolated in 2017 in Switzerland [6].  
Overall, the emergence of carbapenemase producers in this species represents a serious threat, 
especially when the encoding bla genes possess the ability to disseminate horizontally via 
mobile genetic elements (MGEs) among different bacterial hosts. This is the case of the class 
B metallo-β-lactamases of the VIM family that have been described globally in many species 
of Enterobacterales [7]. Nevertheless, to our best knowledge, VIM-producing K. 
michiganensis strains have never been described. 
In the present work, we characterized the first K. michiganensis strain possessing a multi-
drug resistance plasmid encoding the blaVIM-1 carbapenemase gene isolated from a patient 
hospitalized in Switzerland.  




2. MATERIALS AND METHODS 
2.1 Isolation, identification and antimicrobial susceptibility tests (ASTs) 
On January 2018, a 59-years-old Turkish female who suffered from liver cirrhosis came to 
Switzerland for consultation and rehabilitation. No further clinical data are available. At 
admission, the patient underwent rectal swab to screen for multidrug-resistant (MDR) Gram-
negatives. Both ChromID® ESBL and CARBA SMART selective agar plates (bioMérieux) 
were inoculated and incubated overnight at 35-36°C.  
Species identification was routinely obtained using the matrix assisted laser 
desorption/ionization time of flight mass spectrometry (MALDI-TOF-MS; Bruker); it was 
then achieved using whole-genome sequencing (WGS) data and the implementation of the 
Type (Strain) Genome Server (https://tygs.dsmz.de/), which uses a genome-based phylogeny 
approach, together with, for example, digital DNA:DNA hybridization (dDDH) and 
confidence interval support values to infer accurate species identification. ASTs were 
performed using the broth microdilution ESBF and GNX2F Sensititre panels (Thermo-
Fisher). Minimum inhibitory concentrations (MICs) for antibiotics were interpreted according 
to the 2019 European Committee on Antimicrobial Susceptibility Testing (EUCAST) criteria 
(https://www.eucast.org/; version 9.0). The new CT103XL microarray (Check-Points) was 
implemented to screen for the presence of the main carbapenemase and ESBL bla genes [8]. 
  
2.2 Whole-genome sequencing (WGS) 
WGS was performed using both NovaSeq 6000 (Illumina) and MinION (SQK-RBK004 
library; FLO-MIN 106D R9 flow-cell; Oxford Nanopore) sequencing technologies as 
previously described [9]. In brief, the sequencing adapters from both Illumina and Nanopore 
reads were removed using Trimmomatic (v0.36) and Porechop (v0.2.4) with default 
parameters, respectively. A subset of best quality Nanopore reads were extracted with Filtlong 
(v0.2.0) using the Phred quality scores from the FASTQ file. The long-read assembly was 




generated with Canu (v2.1), with approximate genome size set to 6.2 Mb. The subsequent 
assembly was circularized with Circlator (v1.5.5), using Canu as the assembler, and manually 
revised for errors with Nucmer (v3.1). The hybrid  assembly was generated by multiple 
rounds of read correction and alignment with Illumina reads using Pilon (v1.22) and Bowtie2 
(v2.3.4.1). Annotation was performed with the NCBI Prokaryotic Genome Annotation 
Pipeline, and insertion sequences (ISs) were manually curated with ISfinder 
(https://isfinder.biotoul.fr/). The final genome was analyzed using the tools of the CGE 
(www.genomicepidemiology.org/). MLST (v2.0) was performed according to the K. oxytoca 
scheme. Virulence factors were screened with the vfdb database (accessed on 30.11.2020) 
using ABRicate (v1.0.1), and metal resistance genes with AMRfinderPlus (v3.8.4). 
Polysaccharide locus analysis was conducted with the Kaptive webtool (https://kaptive-
web.erc.monash.edu/). 
The blaVIM-1-harbouring integron was classified according to INTEGRALL 
(http://integrall.bio.ua.pt/). The complete genome assembly of BD-50-Km is deposited in 
GenBank (CP061930-CP061933) under BioProject PRJNA664790.  
 
2.3 Core-genome analysis 
The assemblies used for the core-genome analysis were retrieved from the NCBI isolate 
browser using the following queries: “scientific_name: Klebsiella michiganensis” to retrieve 
all available assemblies (n=212 K. michiganensis) and “scientific_name: AND 
AMR_genotypes: blaIMP* blaKPC* blaNDM* blaOXA*” as determined by the unique carbapenem 
genes present in “subclass: CARBAPENEM” in the MicroBIGG-E browser (n=38) 
(access/download date: 23.10.2020).  
To look for other sequence type (ST) 342 strains, the full dataset (n=212) was subjected to an 
in-silico analysis with a custom script using the forward and reverse sequence alleles of 
ST342 (gapA_3, infB_5, mdh_40, pgi_64, phoE_24, rpoB_6, tonB_82) available at PubMLST 




(pubmlst.org/organisms/klebsiella-oxytoca). Closely-related strains were detected by a global 
core-genome alignment of all available 212 K. michiganensis strains (data not shown). The 
tree was visualized with iTOL (v5.6.3; itol.embl.de).   




3. RESULTS AND DISCUSSION 
3.1 Phenotype and screening for carbapenemase genes 
From the selective plates, a Klebsiella oxytoca strain (BD-50-Km) was identified by using the 
MALDI-TOF MS. Nevertheless, based on WGS, BD-50-Km was determined to belong to the 
Klebsiella michiganensis species. As shown in Table 1, the strain was resistant to 
aminoglycosides, β-lactam/β-lactamase combinations and last-generation cephalosporins, and 
also showed a slightly reduced susceptibility to carbapenems (e.g., MICs for imipenem and 
meropenem: 2 and <1 mg/L, respectively). According to the new CT103XL microarray, BD-
50-Km was a blaVIM, blaSHV-1-like, and blaTEM-1-like carrier (data not shown).  
  
3.2 Antimicrobial resistance genes (ARGs), serotype, and virulence factors (VFs) 
BD-50-Km was composed of a chromosome (6.3 Mb) and carried 3 plasmids: pBD-50-
Km_VIM-1 (196.3 kb, IncC (pST1)), pBD-50-Km_2 (202.3 kb, IncR), and pBD-50-Km_3 
(135.6 kb, IncFII(K)). The following ARGs were detected: chromosome (blaOXY-1-7, aph(3’)-
Ia), and plasmid pBD-50-Km_VIM-1 (blaVIM-1, blaOXA-10, blaSHV-2, blaTEM-1B, aac(3)-IId, 
aac(6')-IIc, aadA1, ant(2”)-Ia, aph(3'')-Ib, aph(6)-Id, arr-2, cmIA1, mph(A), qnrA1, sul1, 
∆sul2).  
The blaVIM-1 promoter region was analyzed showing a strong P1 [-35: TTGACA; -10: 
TAAACT] and an inactivated P2 promoter (data not shown). This genetic background could 
not explain the low resistance expressed by BD-50-Km against carbapenems. However, we 
note that a consistent susceptibility pattern for carbapenems was observed for E. cloacae and 
K. pneumoniae isolates carrying the same blaVIM-1 integron cassette as ours (see below) [10, 
11]. 
Lipopolysaccharide (LPS; O), capsular (K) serotypes, and VFs of K. pneumoniae have 
been extensively characterized in the past. For instance, K1/K2 serotypes are linked to 
hypervirulence, and yersiniabactin producers are highly prevalent and frequently associated to 




respiratory infections [12, 13]. In contrast, little is known about the serotypes and VFs of K. 
michiganensis. In this context, BD-50-Km carried novel K and O serotype variants, with a 
closest match to K locus KL161 and O locus O1v1, respectively (data not shown). Similarly, 
BD-50-Km was positive for multiple VF homologues, for instance, coding for yersiniabactin, 
enterobactin,  type VI secretion system, heat-stable enterotoxin, capsule, type 1 fimbriae, and 
others (full results in File S1). Our strain also carried metal resistance genes for silver/copper 
(sil and pco gene families) in pBD-50-Km_2, and for mercury resistance (mer operon), 
present in pBD-50-Km_VIM-1. Heavy metal resistance, such as the mer operon, has been 
reported in multiple species and is an important mercury-detoxification system in 
contaminated environments [14]. 
 
3.3. Clonality and core-genome analyses 
BD-50-Km carried two novel alleles in the pgi and tonB loci, and thus was assigned to the 
new ST342. To look for other strains similar to BD-50-Km and to understand the current 
prevalence of carbapenemase genes in K. michiganensis, we conducted a database search of 
K. michiganensis genomes with the NCBI isolate browser 
(www.ncbi.nlm.nih.gov/pathogens/isolates/).  
Our search resulted in 212 available genomes of which 38 possessed carbapenemase genes of 
IMP-, KPC-, NDM-types, and OXA-181. A core-genome alignment of the 38 genomes along 
with 3 non-carbapenemase producers and BD-50-Km was constructed with Parsnp (v1.2) as 
previously described, and resulted in 178’921 single nucleotide variants (SNVs) [9]. Our 
isolate belonged to a group of K. michiganensis strains of international origin and of various 
STs. In particular it was distantly related to a ST27 cluster containing the Swiss KPC-3 
producer strain KMISG1 (18’784 different SNVs) [6], and to two non-carbapenemase 
producers of ST213 from the USA and UK (18’638 different SNVs) (Figure 1). Our analysis 
confirmed that BD-50-Km is unique and does not belong to a clonal lineage.   





3.4 blaVIM-1-carrying plasmid characterization 
An analysis of the above 42 WGS genomes with PlasmidFinder (v2.1) detected multiple 
replicon sequences per genome (data not shown). Of these, 5 were positive for an IncC 
replicon sequence of similar backbone to pBD-50-Km_VIM-1, but all were blaVIM-negative 
(Figure S1). 
Our blaVIM-1-containing plasmid pBD-50-Km_VIM-1 was most similar to pVb0267 
(MF627444) from V. parahaemolyticus isolated from shrimp in China. However, it also 
shared a similar backbone to other IncC plasmids, such as Shewanella algae p18064-65-CSB-
B isolated from chicken stools in Tanzania [15], and to various multi-host blaVIM-1-possessing 
strains (Figure 2 and Figure S2).  
The blaVIM-1 of pBD-50-Km_VIM-1 was associated to a small class 1 integron (In87) from 
Enterobacter cloacae (AY648125), first described in 2003 in Greece and also carrying the 
aminoglycoside-modifying enzyme aac(6’)-IIc [10]. In87, including its recombination site 
attI (bp positions: 66213-66270), was inserted in between flanking IS elements, IS4321 and 
Tn3 family/IS5075. The same integron was responsible for an outbreak of K. pneumoniae 
bloodstream infections in Italy in 2004-2005 [11]. In Greece, other VIM producers have also 
been responsible for outbreaks [16-18]; moreover, the same In87 has also been detected in 
four Enterobacter hormaechei [7, 19], though none of them was associated to IncC plasmids 
(Figure S3). Likewise, of the other blaVIM-1-positive IncC plasmids identified, none of them 
carried the same blaVIM-1-containing integron cassette as pBD-50-Km_VIM-1, highlighting its 
rarity (Figure S4). 
The remaining ARGs of pBD-50-Km_VIM-1 were carried in a complex region containing 
multiple copies of various IS elements such as IS5075, IS4321, and IS26. Notably, blaSHV-2 
was associated to an IS26 composite transposon also found in plasmid pTC2 from 
Providencia stuartii; and upstream, another class 1 integron carrying ant(2”)-Ia, arr-2, 




cmIA1, blaOXA-10, and aadA1, present also in pVb0267, sharing a similar backbone to ours 
(Figure 2).  





This is the first report of a blaVIM-1-positive K. michiganensis clinical isolate (BD-50-Km). 
The strain harbored a novel IncC plasmid carrying blaVIM-1 associated to a rare integron. 
Core-genome analysis showed that BD-50-Km did not belong to a clonal group. However, 
since the strain was isolated from a Turkish patient, it is likely that BD-50-Km originated 
from that region, where VIM producers have been frequently reported, such as in Klebsiella 
spp. and Enterobacter spp. [19, 20].  
Since its discovery, K. michiganensis has proven to become an important human emerging 
pathogen. However, since this species is frequently misidentified as K. oxytoca by using the 
MALDI-TOF MS [2, 3, 6], information regarding its clonality, plasmid(s) background, 
serotype, and virulence factors is still limited. Therefore, it is imperative to perform more 
surveys to understand the role of K. michiganensis in human infections and its potential to 
acquire life-threatening MDR genes. 
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LEGEND TO THE FIGURES 
 
 
Figure 1. Core-genome analysis of 39 carbapenemase-producing K. michiganensis strains. 
The core-genome alignment and phylogeny were generated with Parsnp (v1.2) and resulted in 
178’921 SNVs and a 64% core-genome alignment across all strains, which included the strain 
BD-50-Km as reference genome, and three non-carbapenemase producers (one Swiss stain 
and two closely-related strains). The tree was visualized with iTOL (v5.6.3; itol.embl.de). The 
tree scale represents the average number of nucleotide substitutions per site. SH-like support 
values are shown in the tree branches. Five IncC replicon sequences were detected in strains 
97_38, CAV1755, GEO_33_Up_A, YD358, and ERS3640381 (Figure S1). NA; Not 
Available.  
1, 2 
Carbapenemase and other bla genes were detected by ResFinder (v4.1). A gene name 
followed by a dash “/” corresponds to multiple or partial hits of the same gene family. For 




strain MGH175, the KPC partial sequence was detected at 40% minimum length with 
ResFinder. 
3
 MLST (v2.0) was performed for all strains according to the K. oxytoca scheme. Strains with 
a nearest ST are represented by a ST-like.  
4
 The carbapenemase location is shown only when the gene is explicitly stated in the genome 
assembly as a plasmid or chromosomal sequence; its location is represented by a colored 
circle, plasmid name, and replicon type. 
 
Figure 2. Circular BLAST comparison of pBD-50-Km_VIM-1 to other similar plasmid 
backbones and the integron region of blaVIM-1. 
(A) Comparison of the sequences of twelve multispecies IncC carrying plasmids. Rings were 
constructed using BRIG (BLAST Ring Image Generator; v0.95). Similarities with pBD-50-
Km_VIM-1 are represented by the colored rings. GenBank accession numbers, plasmid name, 
replicon type and pMLST, plasmid size, main bla, year, country, source, and species are 




indicated in the legend. Annotations above the rings correspond to the gene features of 
interest. The annotations for the tra operons 1 and 2, and repA are shown according to the 
nucleotide sequence alignment to the reference IncC plasmid pNDM-KN (JN157804). A delta 
(∆) symbol before the gene name/feature corresponds to a partial/incomplete CDS; an asterisk 
(*) corresponds to a frameshifted product. 
(B) Linear comparison of the blaVIM-1 integron region against two plasmids with the most 
similar integron regions (MN477204 and KR559890), and the full length (2129bp) of the In87 
reference sequence (AY648125). The start (63278bp) and end (67368bp) positions of the 
integron are shown in red. The linear BLAST comparison was generated with Easyfig 
(v2.2.2). BLAST similarity is represented by the grey area in between the sequence 
alignment. Lines represent BLAST hits. 
 
Table 1. Phenotypic characterization of the VIM-1-producing K. michiganensis 
BD-50-Km 
Antibiotics 
MIC values (mg/L) 
a
 
K. michiganensis BD-50-Km 
a
 
Piperacillin-tazobactam  >64/4 (R) 
Ticarcillin-clavulanate >128/2 (R) 
Cefotaxime 32 (R) 
Cefotaxime-clavulanate 32 (NA) 
Ceftazidime >128 (R) 
Ceftazidime-clavulanate >128 (NA) 
Cefepime 8 (R) 
Aztreonam <2 (S) 
Imipenem 2 (S)  
Meropenem <1 (S) 
Doripenem 0.5 (NA) 
Ertapenem 0.5 (S) 
Gentamicin >16 (R) 
Tobramycin 4 (R) 
Amikacin <4 (S) 




Ciprofloxacin <0.25 (S) 
Levofloxacin <1 (S) 
Doxycycline <2 (NA) 
Minocycline <2 (NA) 
Tigecycline <0.25 (NA) 
Trimethoprim/sulfamethoxazole <0.5/9.5 (S) 
Colistin <0.25 (S) 
Polymyxin B <0.25 (NA) 
Note. R, resistant; I, intermediate; S, susceptible; NA, not available; -, not tested 
a
 MICs were obtained with microdilution Sensititre panels ESBF and GNX2F and interpreted 




         
